The product is made to address what Ronert calls the 4 Ds of GLP-1 skin: deflation, density loss, deep wrinkles, and dehydration
If in fact future studies robustly establish a beneficial effect of the drug class in HF, it may allow for broader adoption of GLP-1 RAs in the prevalent CVD, ultimately contributing to addressing the unmet medical need that continues to persist in the prevention or management of, in particular, HFpEF
Novo Nordisk submitted its application to the FDA to expand the indication for Rybelsus to reduce the risk of MACE in patients with type 2 diabetes and established CVD and/or chronic kidney disease
Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1alpha/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease
Hi, my homocysteine was 4.7 and b12 was 1,045